2019 Cancer Diagnostics Market: Country Market Shares, Profiles of Leading Suppliers
This report presents strategic analyses of major current and emerging suppliers of cancer diagnostic products in terms of their sales, market shares, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
- Abbott
- AdnaGen/Alere
- Agilent Technologies
- Applied Gene Technologies
- Arca Biopharma
- Beckman Coulter/Danaher
- Becton Dickinson
- Biomedical Diagnostics
- bioMerieux
- Bio-Rad
- CellSearch
- Cepheid
- Correlogic Systems/Vermillion
- Decode Genetics
- Diadexus
- Diagnocure
- Diasorin
- Eiken Chemical
- Elitech Group
- Epigenomics
- Enterix
- Enzo Biochem
- Exact Sciences
- Fujirebio
- Guided Therapeutics
- Hologic/Gen-Probe
- Kreatech/Leica
- Kyowa Medex
- Mackay Life Sciences
- Myriad Genetics
- OncoLab
- Ortho-Clinical Diagnostics
- Panacea Pharmaceuticals
- Polartechnics
- Polymedco
- PreMD
- Qiagen
- Quest Diagnostics
- Radient Pharmaceuticals
- Roche
- Scienion
- Sequenom
- Siemens Healthcare
- Takara Bio
- Targeted Diagnostics & Therapeutics
- Thermo Fisher
- Tosoh
- Veridex
- Wako Pure Chemicals
- Wallac/PE
- Zila/Alere
2020 Global Nucleic Acid Testing/NAT Market, 2019-2023: Emerging Opportunities in US, Europe, Japan--Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts--Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing
This new seven-country study contains 1,398 pages, 194 tables, and is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the molecular
USD 24500 View Report2024 Global Nucleic Acid Testing/NAT Market, 2019-2023: Emerging Opportunities in US, Europe, Japan--Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts--Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing
This new seven-country study contains 1,398 pages, 194 tables, and is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the molecular
USD 24500 View Report2024 US Hospital Cancer Diagnostics Market
2024 US Hospital Cancer Diagnostics Market: Supplier Shares by Test, Volume and Sales Segment Forecasts for Major Tumor Markers, Competitive Landscape, Innovative Technologies, Instrumentation Review, Opportunities for SuppliersThis new report
USD 3500 View Report2024 UK Hospital Cancer Diagnostics Market
2024 UK Hospital Cancer Diagnostics Market: Supplier Shares by Test, Volume and Sales Segment Forecasts for Major Tumor Markers, Competitive Landscape, Innovative Technologies, Instrumentation Review, Opportunities for SuppliersThis new report
USD 3500 View ReportFill The Form For Sample Request